| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |